BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2006
View Archived Issues
Heidelberg Pharma report on improved efficacy of novel alovudine prodrug
Read More
Targeting PKC beta for the treatment of diabetic cardiomyopathy
Read More
Emerging targets and molecular markers in head and neck cancer
Read More
Phase I findings for RP-101 with gemcitabine in advanced pancreatic cancer
Read More
Expiration dates confirmed and new agreement for golimumab
Read More
Vicriviroc demonstrates potent and sustained viral suppression in HIV
Read More
Milestone in collaboration between Ortec and ES Cell International
Read More
TAFA-93 shows promise in phase I studies
Read More
Japanese marketing alliance discontinued for Ketek
Read More
QD-3: a novel peptidic HIV-1 fusion inhibitor for drug-resistant viruses
Read More
Preclinical studies confirm that bevirimat is non-teratogenic
Read More
Aptivus/ritonavir efficacious and safe in PI-resistant pediatric patients
Read More
Recent Dainippon patent describes new treatment option for cardiovascular disorders
Read More
Recent patents disclose new therapeutic agents for anxiety, depression, etc.
Read More
Novel antidiabetic compounds disclosed by Sirtris in recent patent
Read More
New Schering patent describes therapeutic agents for allergic and respiratory disorders
Read More
Glypromate shows good pharmacokinetic profile
Read More
CoGenesys and Vegenics sign VEGF licensing agreement
Read More
Stromectol approved in Japan for treatment of scabies
Read More
Alnylam grants Calando license under InterfeRx program
Read More
Canadian approval for Azilect in Parkinson's disease
Read More
ATG-003 begins phase I testing for AMD
Read More
Dynavax's ISS vaccine shows potential as universal flu vaccine
Read More
ASF-1075 studied for psoriasis
Read More